A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective

• Váldodahkkit: Marcus Heise (Dahkki), Petra Staubach (Dahkki), Georgios Nikolakis (Dahkki), Lukas Schollenberger (Dahkki), Melanie Mauch (Dahkki), Marion Burckhardt (Dahkki), Marina Zamsheva (Dahkki), Alexandra Strobel (Dahkki), Gero Langer (Dahkki), Falk Bechara (Dahkki), Uwe Kirschner (Dahkki), Katharina Hennig (Dahkki), Christian Kunte (Dahkki), Matthias Goebeler (Dahkki), Maurizio Podda (Dahkki), Stephan Grabbe (Dahkki), Michael Schultheis (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

AbstractBackground Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting approximately 1% of the population. The patient journey through the German health care system leads to high disease burden and substantial treatment costs. The EsmAiL study showed that an innovative, in...